Familial Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Familial Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies [Phase 3]
Phase 3 study evaluating a fixed-dose combination of obicetrapib and ezetimibe added to existing lipid-modifying therapy has completed. Resu…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies [Phase 3]
Phase 3 randomized study evaluating obicetrapib added to maximum tolerated lipid-modifying therapies has completed, with results posted.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia [NA]
A clinical trial is recruiting to evaluate computerized decision support for identification and management of familial hypercholesterolemia.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers [Phase 1]
Phase 1 clinical trial update reports completion of a Phase 1 study of VSA003 in Chinese adult healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids [Phase 3]
Phase 3 trial update for Enlicitide Decanoate (MK-0616), an oral PCSK9 inhibitor, in adults with hypercholesterolemia, including familial hy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Unravelling the Impact of Diet on Cardiovascular Health in Heterozygous Familial Hypercholesterolemia. [NA]
A completed clinical trial from Laval University examined the impact of diet on cardiovascular health in people with heterozygous familial h…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Cardiovascular Risk in Children With Chronic Conditions Study
Clinical trial update indicates the Cardiovascular Risk in Children With Chronic Conditions Study, sponsored by Semmelweis University, is cu…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Atlantic Lipid Lowering Treatment Optimization Program [NA]
Clinical Trial Update for the Atlantic Lipid Lowering Treatment Optimization Program (NCT06439654) shows recruiting status for multiple lipi…
-
FDA approval · 2025-06-26FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for pravastatin sodium from Dr. Reddy's Laboratories Limited. This pertains to a generic pravastatin…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Patterns of Inclisiran Use in the Real World: An Analysis of US Databases
This clinical trial update analyzes real-world use patterns of inclisiran in US databases for patients with atherosclerotic cardiovascular d…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies. [Phase 3]
A Phase 3 trial evaluating Obicetrapib in patients with familial hypercholesterolemia on maximally tolerated lipid-modifying therapy has com…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry
A prospective German registry completed that collects data on dyslipidemia treatment indications in patients at very high cardiovascular ris…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Child-Parent Familial Hypercholesterolemia Screening
A clinical trial at Children's Hospital of Fudan University is currently recruiting to screen child-parent pairs for familial hypercholester…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH) [EARLY_Phase 1]
An early-phase (Phase 1) clinical trial update for YOLT-101 investigating treatment of familial hypercholesterolemia; the study is currently…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Early Detection of Familial Hypercholesterolemia in Children
A clinical trial recruiting to evaluate early detection of familial hypercholesterolemia in children.
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: The Danish Familial Hypercholesterolemia Organized Coronary Screening Trial [NA]
The entry updates the status of the Danish Familial Hypercholesterolemia Organized Coronary Screening Trial. The trial is currently active b…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Genetic Causes of Familial Hypercholesterolemia
A clinical trial update describing the genetic causes of familial hypercholesterolemia; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Impact of Rosuvastatin Doses on LDL Levels, CPK Levels and Aspartate Aminotransferase Levels [NA]
A completed clinical trial evaluated the effects of different rosuvastatin doses on LDL cholesterol and liver/muscle safety markers (AST and…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis [NA]
This clinical trial aims to integrate whole genome sequencing and digital twin technology to guide management of hypercholesterolemia in Emi…
-
FDA approval · 2025-03-18FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (CIPLA USA INC.)
FDA approved a supplemental application for pravastatin sodium from Cipla USA Inc., authorizing changes to the existing generic product.
-
FDA approval · 2025-03-17FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for pravastatin sodium, a generic statin, approving changes to the product's la…
-
FDA approval · 2025-03-17FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for pravastatin sodium from Accord Healthcare Inc., supporting continued regulatory approval for thi…
-
FDA approval · 2025-03-13FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Novadoz Pharmaceuticals LLC)
FDA approved a supplemental application for atorvastatin calcium filed by Novadoz Pharmaceuticals LLC.
-
FDA approval · 2025-03-12FDA Approved: ROSUVASTATIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for rosuvastatin (generic rosuvastatin), authorizing its marketing in the Unit…
-
FDA approval · 2025-03-11FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for atorvastatin calcium, expanding the availability of a generic statin product.